SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0696+1.6%Nov 5 3:22 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: boomertree2 who wrote (12875)5/23/2014 5:50:33 PM
From: pincus   of 13111
 
Can't get more pissed. I listened to most of the CC. It seems the FDA wanted info about the alleviation of pain, bleeding etc which the company never tested for. They tried to manipulate their Phase II data to meet FDA requests and failed. There was a hint of something when they said they thought CR in 50% meant that their pain was alleviated, but the FDA didn't buy.

Their explanation for the May 16/May 21 fiasco was not strong. In fact, it was weak.

They claim they will work with the NYSE to stay listed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext